A two-phase study of over 2,500 Jordanian children finds that carefully calibrated simple regression models rival or beat ...

aTyr Pharma, Inc. ( ATYR) announced alignment with the U.S. Food and Drug Administration on the protocol for a global Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary ...

Tyr Pharma, Inc. announced that it had reached alignment with the U.S. Food and Drug Administration (FDA) on the protocol for a Phase 3 study of its lead therapeutic candidate, efzofitimod, in ...

Kristina Zucchi is an investment analyst and financial writer with 15+ years of experience managing portfolios and conducting equity research. Katrina Ávila Munichiello is an experienced editor, ...

First clinical evidence demonstrating that a systemically delivered small activating RNA (saRNA) can safely upregulate an endogenous target protein in ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The data establish the first clinical proof-of-mechanism for RNA activation (RNAa) in a human monogenic disease, ...

Angela Ryan Lee, MD, FACC, is a board-certified cardiology and internal medicine physician. She also holds board certifications from the American Society of Nuclear Cardiology and the National Board ...

Phase 3 TETON-1 trial shows inhaled treprostinil improves FVC in IPF, signaling a potential new antifibrotic option. The double-blind trial included 539 patients who underwent randomization of at ...

IMPERIAL Neb. — Input costs are high, and Tim Spector is expanding his crop production playbook to gain an edge for his growers with more plant nutrition and weed control options for the upcoming crop ...

On Planet Normal this week, Liam Halligan and Allison Pearson talk to the former Vote Leave chief executive about how Brexit is working out On this week’s Planet Normal, Allison and Liam speak to Luke ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...